Lok AS - Search Results

1

The scientific basis of combination therapy for chronic hepatitis B functional cure.

Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, Maini MK, Terrault NA, Zoulim F. Lim SG, et al. Among authors: lok as. Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):238-253. doi: 10.1038/s41575-022-00724-5. Epub 2023 Jan 11. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36631717 Review.

2

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference^‡.

Cornberg M, Lok AS, Terrault NA, Zoulim F; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Cornberg M, et al. Among authors: lok as. J Hepatol. 2020 Mar;72(3):539-557. doi: 10.1016/j.jhep.2019.11.003. Epub 2019 Nov 12. J Hepatol. 2020. PMID: 31730789 Free article. Review.

3

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.

Cornberg M, Lok AS, Terrault NA, Zoulim F; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Cornberg M, et al. Among authors: lok as. Hepatology. 2019 Nov 12. doi: 10.1002/hep.31030. Online ahead of print. Hepatology. 2019. PMID: 31713892

4

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

Zoulim F, Buti M, Lok AS. Zoulim F, et al. Among authors: lok as. J Viral Hepat. 2007 Nov;14 Suppl 1:29-36. doi: 10.1111/j.1365-2893.2007.00915.x. J Viral Hepat. 2007. PMID: 17958640 Free article. Review.

5

Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.

Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD; Hepatitis B Research Network (HBRN). Lee WM, et al. J Viral Hepat. 2021 Nov;28(11):1526-1538. doi: 10.1111/jvh.13591. Epub 2021 Aug 11. J Viral Hepat. 2021. PMID: 34355475 Free PMC article.

6

Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.

Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS; Hepatitis B Research Network; Hepatitis B Research Network. Ghany MG, et al. Among authors: lok as. Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92. doi: 10.1016/j.cgh.2014.06.028. Epub 2014 Jul 8. Clin Gastroenterol Hepatol. 2015. PMID: 25010003 Free PMC article.

7

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.

Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A. Dickson RC, et al. Liver Transpl. 2006 Jan;12(1):124-33. doi: 10.1002/lt.20582. Liver Transpl. 2006. PMID: 16382463 Free article. Clinical Trial.

8

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS. Lok AS. J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x. J Gastroenterol Hepatol. 2011. PMID: 21070361

9

Management of viral resistance in the therapy of chronic hepatitis B.

Lok A. Lok A. Gastroenterol Hepatol (N Y). 2008 Dec;4(12):849-51. Gastroenterol Hepatol (N Y). 2008. PMID: 21904473 Free PMC article. No abstract available.

10

Antiviral therapy for chronic hepatitis B.

Jafri SM, Lok AS. Jafri SM, et al. Among authors: lok as. Clin Liver Dis. 2010 Aug;14(3):425-38. doi: 10.1016/j.cld.2010.05.005. Clin Liver Dis. 2010. PMID: 20638023 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

623 results

Search Page